New York Life Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Buy |
801,371
+16,995
| +2% | +$412K | 0.18% | 112 |
|
|
2025
Q1 | $19.9M | Sell |
784,376
-2,144
| -0.3% | -$54.3K | 0.2% | 104 |
|
|
2024
Q4 | $20.9M | Buy |
786,520
+9,007
| +1% | +$239K | 0.2% | 93 |
|
|
2024
Q3 | $22.5M | Sell |
777,513
-24,323
| -3% | -$704K | 0.22% | 95 |
|
|
2024
Q2 | $22.4M | Buy |
801,836
+5,603
| +0.7% | +$157K | 0.23% | 84 |
|
|
2024
Q1 | $22.1M | Sell |
796,233
-27,977
| -3% | -$776K | 0.22% | 86 |
|
|
2023
Q4 | $23.7M | Sell |
824,210
-59,492
| -7% | -$1.71M | 0.24% | 76 |
|
|
2023
Q3 | $29.3M | Sell |
883,702
-3,711
| -0.4% | -$123K | 0.32% | 60 |
|
|
2023
Q2 | $32.6M | Buy |
887,413
+9,642
| +1% | +$354K | 0.34% | 54 |
|
|
2023
Q1 | $35.8M | Buy |
877,771
+12,038
| +1% | +$491K | 0.4% | 44 |
|
|
2022
Q4 | $44.4M | Sell |
865,733
-1,317
| -0.2% | -$67.5K | 0.51% | 34 |
|
|
2022
Q3 | $37.9M | Buy |
867,050
+1,403
| +0.2% | +$61.4K | 0.46% | 38 |
|
|
2022
Q2 | $45.4M | Buy |
+865,647
| New | +$45.4M | 0.53% | 32 |
|